Studies with an artificial endocrine pancreas. 1977

A M Albisser, and B S Leibel, and B Zinman, and F T Murray, and W Zingg, and C K Botz, and A Denoga, and E B Marliss

Short-term studies with an artificial endocrine pancreas have provided insights into the pathophysiology of diabetes and demonstrated the ability of such a system to restore and maintain glucose homeostasis in human subjects given either their usual diet, a 50 gm oral glucose tolerance test, or a moderate level of physical exercise. Animals were used to demonstrate that a peripheral route of insulin delivery by the artificial pancreas is equivalent to the portal route.

UI MeSH Term Description Entries
D007328 Insulin A 51-amino acid pancreatic hormone that plays a major role in the regulation of glucose metabolism, directly by suppressing endogenous glucose production (GLYCOGENOLYSIS; GLUCONEOGENESIS) and indirectly by suppressing GLUCAGON secretion and LIPOLYSIS. Native insulin is a globular protein comprised of a zinc-coordinated hexamer. Each insulin monomer containing two chains, A (21 residues) and B (30 residues), linked by two disulfide bonds. Insulin is used as a drug to control insulin-dependent diabetes mellitus (DIABETES MELLITUS, TYPE 1). Iletin,Insulin A Chain,Insulin B Chain,Insulin, Regular,Novolin,Sodium Insulin,Soluble Insulin,Chain, Insulin B,Insulin, Sodium,Insulin, Soluble,Regular Insulin
D010179 Pancreas A nodular organ in the ABDOMEN that contains a mixture of ENDOCRINE GLANDS and EXOCRINE GLANDS. The small endocrine portion consists of the ISLETS OF LANGERHANS secreting a number of hormones into the blood stream. The large exocrine portion (EXOCRINE PANCREAS) is a compound acinar gland that secretes several digestive enzymes into the pancreatic ductal system that empties into the DUODENUM.
D001786 Blood Glucose Glucose in blood. Blood Sugar,Glucose, Blood,Sugar, Blood
D003920 Diabetes Mellitus A heterogeneous group of disorders characterized by HYPERGLYCEMIA and GLUCOSE INTOLERANCE.
D004195 Disease Models, Animal Naturally-occurring or experimentally-induced animal diseases with pathological processes analogous to human diseases. Animal Disease Model,Animal Disease Models,Disease Model, Animal
D004285 Dogs The domestic dog, Canis familiaris, comprising about 400 breeds, of the carnivore family CANIDAE. They are worldwide in distribution and live in association with people. (Walker's Mammals of the World, 5th ed, p1065) Canis familiaris,Dog
D005082 Physical Exertion Expenditure of energy during PHYSICAL ACTIVITY. Intensity of exertion may be measured by rate of OXYGEN CONSUMPTION; HEAT produced, or HEART RATE. Perceived exertion, a psychological measure of exertion, is included. Physical Effort,Effort, Physical,Efforts, Physical,Exertion, Physical,Exertions, Physical,Physical Efforts,Physical Exertions
D005230 Fatty Acids, Nonesterified FATTY ACIDS found in the plasma that are complexed with SERUM ALBUMIN for transport. These fatty acids are not in glycerol ester form. Fatty Acids, Free,Free Fatty Acid,Free Fatty Acids,NEFA,Acid, Free Fatty,Acids, Free Fatty,Acids, Nonesterified Fatty,Fatty Acid, Free,Nonesterified Fatty Acids
D005934 Glucagon A 29-amino acid pancreatic peptide derived from proglucagon which is also the precursor of intestinal GLUCAGON-LIKE PEPTIDES. Glucagon is secreted by PANCREATIC ALPHA CELLS and plays an important role in regulation of BLOOD GLUCOSE concentration, ketone metabolism, and several other biochemical and physiological processes. (From Gilman et al., Goodman and Gilman's The Pharmacological Basis of Therapeutics, 9th ed, p1511) Glucagon (1-29),Glukagon,HG-Factor,Hyperglycemic-Glycogenolytic Factor,Proglucagon (33-61),HG Factor,Hyperglycemic Glycogenolytic Factor
D005951 Glucose Tolerance Test A test to determine the ability of an individual to maintain HOMEOSTASIS of BLOOD GLUCOSE. It includes measuring blood glucose levels in a fasting state, and at prescribed intervals before and after oral glucose intake (75 or 100 g) or intravenous infusion (0.5 g/kg). Intravenous Glucose Tolerance,Intravenous Glucose Tolerance Test,OGTT,Oral Glucose Tolerance,Oral Glucose Tolerance Test,Glucose Tolerance Tests,Glucose Tolerance, Oral

Related Publications

A M Albisser, and B S Leibel, and B Zinman, and F T Murray, and W Zingg, and C K Botz, and A Denoga, and E B Marliss
January 1980, Fortschritte der Medizin,
A M Albisser, and B S Leibel, and B Zinman, and F T Murray, and W Zingg, and C K Botz, and A Denoga, and E B Marliss
September 2001, Journal of the American College of Surgeons,
A M Albisser, and B S Leibel, and B Zinman, and F T Murray, and W Zingg, and C K Botz, and A Denoga, and E B Marliss
December 1990, Nihon rinsho. Japanese journal of clinical medicine,
A M Albisser, and B S Leibel, and B Zinman, and F T Murray, and W Zingg, and C K Botz, and A Denoga, and E B Marliss
March 1979, Khirurgiia,
A M Albisser, and B S Leibel, and B Zinman, and F T Murray, and W Zingg, and C K Botz, and A Denoga, and E B Marliss
November 1989, Nihon rinsho. Japanese journal of clinical medicine,
A M Albisser, and B S Leibel, and B Zinman, and F T Murray, and W Zingg, and C K Botz, and A Denoga, and E B Marliss
September 2002, Nihon rinsho. Japanese journal of clinical medicine,
A M Albisser, and B S Leibel, and B Zinman, and F T Murray, and W Zingg, and C K Botz, and A Denoga, and E B Marliss
January 1979, Hormone and metabolic research. Supplement series,
A M Albisser, and B S Leibel, and B Zinman, and F T Murray, and W Zingg, and C K Botz, and A Denoga, and E B Marliss
March 1985, Clinical chemistry,
A M Albisser, and B S Leibel, and B Zinman, and F T Murray, and W Zingg, and C K Botz, and A Denoga, and E B Marliss
July 1979, Journal of clinical chemistry and clinical biochemistry. Zeitschrift fur klinische Chemie und klinische Biochemie,
A M Albisser, and B S Leibel, and B Zinman, and F T Murray, and W Zingg, and C K Botz, and A Denoga, and E B Marliss
January 2010, Surgery today,
Copied contents to your clipboard!